Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 20.6
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Zenlabs Ethica Ltd. engages in trading of pharmaceutical products. Its products include: Analgesics and Anti-Inflammatory; Skin Preparations; Neurological Disorders; Ear, Eye, and Nasal Drops; Anti-Diabetic; Anti-Depressant; Antiviral; Anti-Emetic; Steroids and Anabolic Steroids; Anti-Hypertensive Drugs; Anti Allergic, Anti Cold, and Cough Syrup; Nutraceuticals; Antacid, Enzymes, and Appetite Stimulant; Ayurvedic Preparation; GIT Disorders; and Other Pharmaceutical Drugs....
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is overpriced on P/E, 'cheap' on EV/E
Data is available to registered users only
Buy
Sell